MTOR and Hepatic steatosis: Pharmacologic inhibition of mTOR by torin-1, a novel mTOR inhibitor, could reverse the inhibition of TFEB, liver steatosis, and liver injury in chronic-plus-binge alcohol treatment, suggesting a potential association between the mTOR pathway and TFEB inhibition by alcohol [72].